New drug has potential to turn COVID-19 virus against itself (IMAGE)
Caption
A drug developed by Scripps Research scientists prevents SARS-CoV-2 (blue) from binding to ACE2 receptors (pink) to infect human cells. The drug latches on to the virus and then adds a “nitro group” similar to nitroglycerin to ACE2 whenever the drug-coated virus approaches the receptor.
Credit
Scripps Research
Usage Restrictions
With related coverage and credit
License
Original content